HTLV seroprevalence in people using HIV pre-exposure prophylaxis in England

by | Feb 12, 2023 | Publications

J Infect. 2023 Feb 9:S0163-4453(23)00054-3. doi: 10.1016/j.jinf.2023.01.033. Online ahead of print.


OBJECTIVES: HTLV-1 is predominantly a sexually-transmitted infection but testing is not mentioned in HIV-PrEP guidelines. We ascertained HTLV-1/HTLV-2 seroprevalence amongst HIV-PrEP users in England.

METHODS: An unlinked anonymous seroprevalence study.

RESULTS: Amongst 2015 HIV-PrEP users, 95% were men, 76% of white ethnicity and 83% had been born in Europe. There were no HTLV-1/HTLV-2 seropositive cases (95% confidence interval 0% – 0.18%).

CONCLUSIONS: There were no HTLV positive cases, likely reflecting the demographic of mostly white and European-born individuals. Similar studies are needed worldwide to inform public health recommendations for HIV-PrEP using populations, particularly in HTLV-endemic settings.

PMID:36773896 | DOI:10.1016/j.jinf.2023.01.033

Other publications you may be interested in…

HTLV-1 Disease

HTLV-1 Disease

HTLV-1 Disease Abstract The years 2020 and 2021 will remain memorable years for many reasons [...]. Click here to...

read more